about
Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infectionsRisk Environments, Race/Ethnicity, and HIV Status in a Large Sample of People Who Inject Drugs in the United StatesAN EMPIRICAL TEST OF RESPONDENT-DRIVEN SAMPLING: POINT ESTIMATES, VARIANCE, DEGREE MEASURES, AND OUT-OF-EQUILIBRIUM DATA.SOCIAL NETWORK ANALYSIS WITH RESPONDENT-DRIVEN SAMPLING DATA: A STUDY OF RACIAL INTEGRATION ON CAMPUS.Increases in HIV testing among men who have sex with men--National HIV Behavioral Surveillance System, 20 U.S. Metropolitan Statistical Areas, 2008 and 2011.Statistical methods for the analysis of time-location sampling dataHIV infection and awareness among men who have sex with men-20 cities, United States, 2008 and 2011Increases in recent HIV testing among men who have sex with men coincide with the Centers for Disease Control and Prevention's expanded testing initiative.Early Linkage to HIV Care and Antiretroviral Treatment among Men Who Have Sex with Men--20 Cities, United States, 2008 and 2011.Population Size Estimates for Men who Have Sex with Men and Persons who Inject DrugsEstimating design effect and calculating sample size for respondent-driven sampling studies of injection drug users in the United States.Respondent-Driven Sampling of Heterosexuals at Increased Risk of HIV Infection.Assessing the assumptions of respondent-driven sampling in the national HIV Behavioral Surveillance System among injecting drug users.Updated Data on Linkage to Human Immunodeficiency Virus Care and Antiretroviral Treatment Among Men Who Have Sex With Men-20 Cities, United States.Racialized risk environments in a large sample of people who inject drugs in the United States.Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009Network analysis among HIV-infected young black men who have sex with men demonstrates high connectedness around few venues.Social network characteristics and HIV vulnerability among transgender persons in San Salvador: identifying opportunities for HIV prevention strategies.Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012.Cross-sectional association between ZIP code-level gentrification and homelessness among a large community-based sample of people who inject drugs in 19 US cities.Syphilis Screening and Diagnosis Among Men Who Have Sex With Men, 2008-2014, 20 U.S. Cities.Achieving Greater HIV Prevention Impact Through CDC's National HIV Behavioral Surveillance System.Estimated HIV Inter-test Interval Among People at High Risk for HIV Infection in the U.S.Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States.Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.Policy Changes and Improvements in Health Insurance Coverage Among MSM: 20 U.S. Cities, 2008-2014.Trends in condom use among MSM in the United States: the role of antiretroviral therapy and seroadaptive strategies.Surveillance Among Men Who have Sex with Men in the United States: A Comparison of Web-Based and Venue-Based Samples.Age-Specific Race and Ethnicity Disparities in HIV Infection and Awareness Among Men Who Have Sex With Men--20 US Cities, 2008-2014.HIV infection and HIV-associated behaviors among persons who inject drugs--20 cities, United States, 2012.HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection--National HIV Behavioral Surveillance System, 21 U.S. cities, 2010.HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
P50
Q28538968-FFEB510F-A029-4E9A-9064-11730B42F6C5Q28550727-CF1AFBD6-F0E8-475E-B36C-2E1D9222D820Q33531691-BA09A1F7-C809-42A3-8239-1BF730507F37Q33552276-F918AEFF-7343-481C-8DC9-5C065C2EC41AQ34121077-2E2E981D-57A1-4A4C-AB86-D71FE05578ECQ34197442-87583D58-7B5E-4863-8A86-521C13ECDC97Q34382832-E0DFA065-A845-4DEF-8DAF-DC3C6BCF7A78Q35451820-F4F3453E-BB79-4CCD-9F3B-821BA3DCE43BQ35692163-9C0CB1D0-D7F1-4E55-8864-4C0585DCBC10Q35916024-DD8EB33B-0174-4D25-BEA6-AA52CB38F348Q36056824-87FA5383-B6EC-451E-8D54-B43F8CF84558Q36122575-7A896E56-41FA-4456-94ED-2FA5BC2D0216Q36291591-80DAD1C0-BAEB-47FD-B8F3-830774FE35FAQ36331581-632D18E6-B3A5-44EE-AA04-0CB2AF4B69F7Q36471364-E8443165-09B1-411C-935E-F79327EADDC0Q37040594-1C93F0F1-A9B9-434E-BEEF-10F1BA908980Q37096660-D4FE5DDD-7A95-48A9-AB9B-BA8636B7CA45Q37453896-EEDDF07D-1A40-4528-86B2-AC60CFED9F86Q37466864-395D9010-8EFA-4DB1-BD32-EFD383C85D7EQ38715081-7152230C-FF5D-4A7D-808E-D3D9CFB74C02Q38730572-7CDB1E29-E8F7-4177-8F38-BD590F4B1BA6Q38730624-7DFE23FC-54AF-40E0-A7F5-13BF71A5EA4CQ38740685-E899E7ED-EDED-46BC-A6F6-34BBBF8A1784Q38826295-876FB3C2-A7CA-4E01-9F2D-907998E2B841Q39139379-F6E1F667-0CE9-462F-AA34-DF23DA64F6D2Q39257940-41F5A5B5-B0A1-4839-AAB6-F8A117BCD9FEQ39791811-6EBAD6B3-C3C3-468E-B4C6-CD538B244316Q40138765-777B3983-D9C2-4314-839F-9999BB7028EAQ40408968-3138C52C-2B61-4538-93D3-59A3A25BD1B6Q41193569-9EF33239-5663-4614-8666-AEECA627B7DDQ41592285-0AB3B66A-B291-48C9-9C39-748CF4786BACQ42208540-65DC2845-BA1D-46F4-91B2-0F93008ECEC2
P50
description
onderzoeker
@nl
name
Cyprian Wejnert
@ast
Cyprian Wejnert
@en
Cyprian Wejnert
@es
Cyprian Wejnert
@nl
Cyprian Wejnert
@sl
type
label
Cyprian Wejnert
@ast
Cyprian Wejnert
@en
Cyprian Wejnert
@es
Cyprian Wejnert
@nl
Cyprian Wejnert
@sl
prefLabel
Cyprian Wejnert
@ast
Cyprian Wejnert
@en
Cyprian Wejnert
@es
Cyprian Wejnert
@nl
Cyprian Wejnert
@sl
P106
P21
P31
P569
2000-01-01T00:00:00Z